Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2020-04-20 Capital/Financing Update
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권취득결정
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (Lumi Micro) regarding the acquisition of shares in another corporation (Vivozon). It details the correction of a previous filing (amendment) concerning the acquisition date, share count, and investment amount. This type of disclosure regarding corporate investment and capital allocation falls under the 'Regulatory Filings' category as it is a specific corporate action announcement that does not fit into the other specialized categories like M&A (which usually implies a merger or takeover) or Share Issue.
2020-04-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when a company director or major shareholder changes their shareholding position. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by a company executive (Lee Doo-hyun).
2020-04-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease in stake due to stock sales and early redemption of convertible bonds) by a major shareholder (NIKE 1st Fund). This type of filing is used to notify the market of significant changes in shareholding levels, which corresponds to the 'Major Shareholding Notification' category.
2020-04-13 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여에 관한 신고). It details the terms, conditions, and recipients of the stock options. Since this is a specific regulatory disclosure regarding corporate capital/equity structure changes (stock options) that does not fit into the other specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes), it is classified as a Regulatory Filing (RNS).
2020-03-31 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2019 (2019.01.01-2019.12.31) for Lumimicro Co., Ltd. It contains detailed financial statements, management analysis, governance information, and audit opinions, which are the core components of an Annual Report (10-K equivalent in the Korean market). FY 2019
2020-03-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used by executives and major shareholders to report changes in their shareholdings in a company (in this case, Lumimicro Co., Ltd.). This type of filing is classified as 'Director's Dealing' (DIRS) as it details personal share transactions by company insiders.
2020-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.